Hereditary thrombotic thrombocytopenic purpura and COVID-19: impacts of vaccination and infection in this rare disease

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F22%3A00013474" target="_blank" >RIV/00023736:_____/22:00013474 - isvavai.cz</a>
Alternative codes found
RIV/00843989:_____/22:E0109846
Result on the web
<a href="https://doi.org/10.1002/rth2.12814" target="_blank" >https://doi.org/10.1002/rth2.12814</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/rth2.12814" target="_blank" >10.1002/rth2.12814</a>

Result language
angličtina
Original language name
Hereditary thrombotic thrombocytopenic purpura and COVID-19: impacts of vaccination and infection in this rare disease
Original language description
Severe COVID-19 is associated with an important increase of von Willebrand factor and mild lowering of ADAMTS13 activity that may, in the presence of a strong inflammatory reaction, increase the risk of acute thrombotic thrombocytopenic purpura (TTP). Although acute episodes of immune-mediated TTP associated with COVID-19 or SARS-CoV-2 vaccination have been reported, data about clinical evolution of hereditary TTP (hTTP) during the pandemic are scarce. We conducted a survey among adult patients of the International Hereditary TTP Registry about SARS-CoV-2 vaccination, COVID-19, and occurrence of acute hTTP episodes.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)